HL 010183

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 2021

CAS [1429218-03-0]

MF C14H20N6.HCl
MW 308.81

  • Purity: 99%
  • Soluble in DMSO

HL 010183

Description

A metformin derivative exerting a potent anti-tumor effect; HL010183 inhibits proliferation and invasion of Hs578T triple-negative (TN) breast cancer cells; 100 fold more potent than metformin.

KEYWORDS: HL 010183 | supplier | Antitumor agent | HL010183 | HL-010183 | CAS [1429218-03-0] | [1125365-14-1] | Glucose | Homeostasis | AMPK | metformin | anti-tumor | proliferation | Hs578T | breast cancer

Order
Size Unit Price Stock
10 mg €135.00 In Stock
50 mg €475.00 In Stock
Special Offers
Size Unit Price Stock
2 x 10 mg €200.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...